Safe Harbor now posted profits for the past three quarters, with interest income making more gains despite revenue slumping ...

The biotech will concentrate on non-hallucinogenic compounds, especially following recent FDA concerns on psychedelic trial ...

The company did not specify in Tuesday's announcement whether previously announced layoffs and closures would be reversed.

Officials got through a slew of items, including CAURD extensions and revised rules allowing cash-strapped medical operators ...

Management sees "long-term margin improvement" after GrowCo integration, though it may face huge duties in Israel amid an ...

Independent stores lead the way for overall sales of intoxicating hemp products compared with chain stores. Chain stores beat ...